Terms: = Lung cancer AND CREB3L2, MGC131709, 64764, ENSG00000182158, TCAG_1951439, BBF2H7, MGC71006
5 results:
1. Sclerosing Epithelioid Fibrosarcoma: A Distinct Sarcoma With Aggressive Features.
Warmke LM; Meis JM
Am J Surg Pathol; 2021 Mar; 45(3):317-328. PubMed ID: 32769431
[TBL] [Abstract] [Full Text] [Related]
2. Sclerosing epithelioid fibrosarcoma: cytologic characterization with histologic, immunohistologic, molecular, and clinical correlation of 8 cases.
Porteus C; Gan Q; Gong Y; Pantanowitz L; Henderson-Jackson E; Saeed-Vafa D; Mela N; Peterson D; Ahmad N; Ahmed A; Bui M
J Am Soc Cytopathol; 2020; 9(6):513-519. PubMed ID: 32624384
[TBL] [Abstract] [Full Text] [Related]
3. Low-grade fibromyxoid sarcoma of the extremities: a clinicopathologic study of 24 cases and review of the literature.
Sambri A; Righi A; Tuzzato G; Donati D; Bianchi G
Pol J Pathol; 2018; 69(3):219-225. PubMed ID: 30509048
[TBL] [Abstract] [Full Text] [Related]
4. Fusion of the FUS and creb3l2 genes in a supernumerary ring chromosome in low-grade fibromyxoid sarcoma.
Bartuma H; Möller E; Collin A; Domanski HA; Von Steyern FV; Mandahl N; Mertens F
Cancer Genet Cytogenet; 2010 Jun; 199(2):143-6. PubMed ID: 20471519
[TBL] [Abstract] [Full Text] [Related]
5. Hyalinizing spindle cell tumor with giant rosettes arising in the lung: report of a case with FUS-creb3l2 fusion transcripts.
Kim L; Yoon YH; Choi SJ; Han JY; Park IS; Kim JM; Chu YC; Kim YJ
Pathol Int; 2007 Mar; 57(3):153-7. PubMed ID: 17295648
[TBL] [Abstract] [Full Text] [Related]
